{"id":341180,"date":"2025-08-20T14:16:15","date_gmt":"2025-08-20T14:16:15","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-atai-life-sciences-nv\/"},"modified":"2025-08-20T14:16:15","modified_gmt":"2025-08-20T14:16:15","slug":"how-to-buy-atai-life-sciences-nv","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/","title":{"rendered":"Atai Life Sciences N.V. (ATAI) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Atai Life Sciences N.V. (ATAI) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334090,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-341180","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Atai Life Sciences N.V. (ATAI) Hisseleri Nas\u0131l Al\u0131n\u0131r - ATAI Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Atai Life Sciences N.V. (ATAI) Hisseleri Nas\u0131l Al\u0131n\u0131r - ATAI Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Atai Life Sciences N.V. (ATAI) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 ve g\u00fcncel fiyat\u0131 $3.99, 6 ayl\u0131k analiz ve 2025-2030 fiyat tahminleri ile ATAI hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Atai Life Sciences N.V. (ATAI) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 ve g\u00fcncel fiyat\u0131 $3.99, 6 ayl\u0131k analiz ve 2025-2030 fiyat tahminleri ile ATAI hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin."},"intro":"Zihinsel sa\u011fl\u0131k tedavisinin gelece\u011fine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Atai Life Sciences, psikedelik t\u0131p devriminde en heyecan verici ancak volatil f\u0131rsatlardan birini temsil ediyor. Bu \u015firket, \u00e7\u0131\u011f\u0131r a\u00e7an bilim ile b\u00fcy\u00fck pazar potansiyelinin kesi\u015fim noktas\u0131nda yer al\u0131yor\u2014y\u00fcksek risk, y\u00fcksek \u00f6d\u00fcl senaryolar\u0131n\u0131 anlayan yat\u0131r\u0131mc\u0131lar i\u00e7in m\u00fckemmel. Mevcut hisse performans\u0131ndan, sizi \u00f6n\u00fcm\u00fczdeki on y\u0131l\u0131n zihinsel sa\u011fl\u0131k tedavisi dalgas\u0131na haz\u0131rlayabilecek pratik sat\u0131n alma stratejilerine kadar her \u015feyi detayland\u0131raca\u011f\u0131z.","intro_source":{"label":"Intro","type":"text","formatted_value":"Zihinsel sa\u011fl\u0131k tedavisinin gelece\u011fine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Atai Life Sciences, psikedelik t\u0131p devriminde en heyecan verici ancak volatil f\u0131rsatlardan birini temsil ediyor. Bu \u015firket, \u00e7\u0131\u011f\u0131r a\u00e7an bilim ile b\u00fcy\u00fck pazar potansiyelinin kesi\u015fim noktas\u0131nda yer al\u0131yor\u2014y\u00fcksek risk, y\u00fcksek \u00f6d\u00fcl senaryolar\u0131n\u0131 anlayan yat\u0131r\u0131mc\u0131lar i\u00e7in m\u00fckemmel. Mevcut hisse performans\u0131ndan, sizi \u00f6n\u00fcm\u00fczdeki on y\u0131l\u0131n zihinsel sa\u011fl\u0131k tedavisi dalgas\u0131na haz\u0131rlayabilecek pratik sat\u0131n alma stratejilerine kadar her \u015feyi detayland\u0131raca\u011f\u0131z."},"body_html":"<h2>\ud83d\udcc8 Atai Life Sciences Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2> <p><strong>20 A\u011fustos 2025 itibar\u0131yla Atai Life Sciences (ATAI) $3.99 seviyesinde i\u015flem g\u00f6r\u00fcyor<\/strong>\u2014birka\u00e7 ay \u00f6nceki 52 haftal\u0131k d\u00fc\u015f\u00fck seviyesi $1.03'ten kayda de\u011fer bir toparlanma. Hisse, %209,16'l\u0131k bir y\u0131ll\u0131k getiri ile patlay\u0131c\u0131 bir b\u00fcy\u00fcme g\u00f6sterdi ve bu y\u00fckselen sekt\u00f6r\u00fcn a\u015f\u0131r\u0131 volatilitesini ve potansiyelini ortaya koyuyor.<\/p> <p><strong>Takviminize not edin: 12 Kas\u0131m 2025 kesinlikle kritik.<\/strong> ATAI'nin 3. \u00e7eyrek kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 tarih bu ve tarihsel olarak bu a\u00e7\u0131klamalar hisse fiyat\u0131n\u0131 dramatik \u015fekilde etkiliyor. \u015eirket, beklentileri a\u015fma konusunda g\u00fc\u00e7l\u00fc bir model olu\u015fturdu\u201414 A\u011fustos 2025'teki 2. \u00e7eyrek raporu net zararda %51,6 azalma ile $27,7 milyon ve gelirde %163,4 art\u0131\u015f ile $719.000 olarak ger\u00e7ekle\u015fti.<\/p> <h3>Tarihsel Kazan\u00e7 Etkisi Analizi<\/h3> <p>Model a\u00e7\u0131k: ATAI beklentileri a\u015ft\u0131\u011f\u0131nda, yat\u0131r\u0131mc\u0131lar co\u015fkuyla tepki veriyor. Geriye d\u00f6n\u00fck testler, kazan\u00e7 a\u00e7\u0131klamalar\u0131ndan sonra hisse senedinin sekt\u00f6r rakiplerini <strong>%60 kazanma oran\u0131 ve a\u00e7\u0131klamalar\u0131 takip eden 10 g\u00fcnl\u00fck d\u00f6nemlerde ortalama %6,35 getiri ile<\/strong> geride b\u0131rakt\u0131\u011f\u0131n\u0131 g\u00f6steriyor. 2025 1. \u00e7eyrek kazan\u00e7lar\u0131 beklentileri %16,67 a\u015farken, 2. \u00e7eyrek $84,75M net zarar a\u00e7\u0131klamas\u0131na ra\u011fmen bu olumlu trend devam etti.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: M\u00fccadeleden Patlamaya<\/h2> <p>ATAI'nin son performans\u0131 dramatik bir d\u00f6n\u00fc\u015f\u00fcm hikayesi anlat\u0131yor. \u015eubat'tan A\u011fustos 2025'e kadar hisse, biyoteknoloji sekt\u00f6r\u00fcndeki en dikkat \u00e7ekici toparlanmalardan birini ya\u015fad\u0131:<\/p> <ul> <li><strong>\u015eubat 2025<\/strong>: $1,45-$2,56 aral\u0131\u011f\u0131nda i\u015flem g\u00f6rd\u00fc (%10,97 ayl\u0131k kazan\u00e7)<\/li> <li><strong>Mart 2025<\/strong>: $1,31-$1,73 aral\u0131\u011f\u0131na \u00e7ekildi (%20,93 d\u00fc\u015f\u00fc\u015f)<\/li> <li><strong>Nisan 2025<\/strong>: $1,15-$1,56 aral\u0131\u011f\u0131nda \u0131l\u0131ml\u0131 toparlanma (%10,29 kazan\u00e7)<\/li> <li><strong>May\u0131s 2025<\/strong>: $2,38 y\u00fcksek seviyesine patlama (%54,00 art\u0131\u015f)<\/li> <li><strong>Haziran 2025<\/strong>: $2,00-$2,64 aral\u0131\u011f\u0131nda konsolidasyon (%5,19 hafif d\u00fc\u015f\u00fc\u015f)<\/li> <li><strong>Temmuz 2025<\/strong>: Klinik kataliz\u00f6r etkisiyle $4,00 seviyesine s\u0131\u00e7rama (%51,14 patlama)<\/li> <\/ul> <p>Bu ivmenin kayna\u011f\u0131? <strong>Temmuz ay\u0131ndaki BPL-003 i\u00e7in Faz 2b sonu\u00e7lar\u0131<\/strong>\u2014depresyon i\u00e7in intranazal mebufotenin tedavileri\u2014\"g\u00fc\u00e7l\u00fc, h\u0131zl\u0131 ve kal\u0131c\u0131 antidepresan etkiler\" g\u00f6sterdi ve hisseleri tek seansta %20'den fazla y\u00fckseltti.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <h3>K\u0131sa Vadeli Projeksiyonlar (2025-2026)<\/h3> <p>Analistler, <strong>2025 i\u00e7in ortalama fiyat hedefini $4,28<\/strong> olarak \u00f6ng\u00f6r\u00fcyor; beklentiler $3,45 ile $5,11 aras\u0131nda de\u011fi\u015fiyor. 2026 i\u00e7in yapay zeka tabanl\u0131 modeller, klinik deneme sonu\u00e7lar\u0131n\u0131n belirsizli\u011fini yans\u0131tarak yakla\u015f\u0131k <strong>$4,06-$4,39<\/strong> aras\u0131nda daha m\u00fctevaz\u0131 bir b\u00fcy\u00fcme \u00f6ng\u00f6r\u00fcyor.<\/p> <h3>Uzun Vadeli Vizyon (2028-2030)<\/h3> <p>2028-2030 i\u00e7in spesifik hedefler biyoteknoloji yat\u0131r\u0131mlar\u0131n\u0131n spek\u00fclatif do\u011fas\u0131 nedeniyle mevcut de\u011fil, ancak temel piyasa dinamikleri muazzam potansiyel g\u00f6steriyor. Psikedelik t\u0131p pazar\u0131 2024'te 2,7 milyar dolardan <strong>2031'de 7,35+ milyar dolara<\/strong> b\u00fcy\u00fcmesi bekleniyor ve ATAI'nin geli\u015fmi\u015f \u00fcr\u00fcn hatt\u0131 \u00f6nemli pazar pay\u0131 yakalamaya haz\u0131r.<\/p> <p><strong>Sonu\u00e7: R\u0130SK TOLERANSI Y\u00dcKSEK yat\u0131r\u0131mc\u0131lar i\u00e7in G\u00dc\u00c7L\u00dc ALIM<\/strong>\u2014d\u00fc\u015f\u00fck de\u011ferleme, klinik ilerleme ve b\u00fcy\u00fck pazar potansiyelinin birle\u015fimi asimetrik bir risk-\u00f6d\u00fcl f\u0131rsat\u0131 yarat\u0131yor.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Reg\u00fclasyon belirsizli\u011fi<\/strong>: FDA onay s\u00fcre\u00e7leri \u00f6ng\u00f6r\u00fclemez ve ticarile\u015fmeyi y\u0131llarca geciktirebilir<\/li> <li><strong>Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong>: \u0130la\u00e7 adaylar\u0131n\u0131n %90'\u0131 geli\u015ftirme a\u015famas\u0131nda ba\u015far\u0131s\u0131z olur\u2014ATAI'nin t\u00fcm de\u011feri ba\u015far\u0131l\u0131 denemelere ba\u011fl\u0131<\/li> <li><strong>Nakit t\u00fcketimi<\/strong>: $95,9 milyon nakit pozisyonu mevcut t\u00fcketim h\u0131z\u0131nda ancak 2027 sonuna kadar yeterli<\/li> <li><strong>A\u015f\u0131r\u0131 volatilite<\/strong>: 1,55 beta de\u011feri, genel piyasadan %55 daha fazla volatilite anlam\u0131na gelir<\/li> <\/ul> <h3>2025-2026 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>At\u0131l\u0131m tedavi tan\u0131m\u0131<\/strong>: FDA, birka\u00e7 psikedelik program i\u00e7in h\u0131zland\u0131r\u0131lm\u0131\u015f stat\u00fc verdi<\/li> <li><strong>2025'te $140 milyon fon topland\u0131<\/strong>: Son fonlama g\u00fc\u00e7l\u00fc yat\u0131r\u0131mc\u0131 g\u00fcvenini g\u00f6steriyor<\/li> <li><strong>Beckley Psytech birle\u015fmesi<\/strong>: Stratejik birle\u015fme \u00fcr\u00fcn hatt\u0131n\u0131 ve klinik kaynaklar\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde geni\u015fletti<\/li> <li><strong>Sekt\u00f6r r\u00fczgarlar\u0131<\/strong>: Zihinsel sa\u011fl\u0131k tedavi pazar\u0131 %14,3 CAGR ile b\u00fcy\u00fcyor<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %2-5'inden fazlas\u0131n\u0131 ATAI gibi y\u00fcksek riskli biyoteknoloji hisselerine ay\u0131rmay\u0131n<\/li> <li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong>: Tek seferde b\u00fcy\u00fck al\u0131m yerine, birka\u00e7 ay boyunca k\u00fc\u00e7\u00fck miktarlarda sat\u0131n al\u0131n<\/li> <li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong>: 12 Kas\u0131m kazan\u00e7lar\u0131n\u0131 takip edin\u2014a\u00e7\u0131klama sonras\u0131 %5-10 d\u00fc\u015f\u00fc\u015fte al\u0131m yap\u0131n<\/li> <li><strong>Sekt\u00f6r i\u00e7inde \u00e7e\u015fitlendirin<\/strong>: Reg\u00fclasyon riskini yaymak i\u00e7in di\u011fer psikedelik hisseleri de de\u011ferlendirin<\/li> <\/ol> <p>Espiri: \"ATAI ticareti, psikedelik terapi gibidir\u2014bazen zorlu anlara katlanman\u0131z gerekir ki \u00e7\u0131\u011f\u0131r a\u00e7an i\u00e7g\u00f6r\u00fclere ula\u015fabilesiniz. Ama ger\u00e7ek terapi seans\u0131n\u0131zda g\u00fcn i\u00e7i i\u015flem yapmaya kalkmay\u0131n!\"<\/p> <h2>\u2705 Atai Life Sciences N.V. (ATAI) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir i\u015flem platformu se\u00e7in<\/td><td>NASDAQ eri\u015fimi ve makul komisyon \u00fccretleri sundu\u011fundan emin olun<\/td><\/tr> <tr><td>2<\/td><td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td><td>Kimlik belgeleri sa\u011flay\u0131n\u2014genellikle 1-2 i\u015f g\u00fcn\u00fc s\u00fcrer<\/td><\/tr> <tr><td>3<\/td><td>Fon yat\u0131r\u0131n<\/td><td>Tamamen kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>\"ATAI\" aramas\u0131 yap\u0131n<\/td><td>\u015eirket ad\u0131 de\u011fil, borsa sembol\u00fcn\u00fc kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>Giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n; volatil hisselerde piyasa emirlerinden ka\u00e7\u0131n\u0131n<\/td><\/tr> <tr><td>6<\/td><td>Pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fc belirleyin<\/td><td>Her i\u015flemde sermayenizin %1-2'sinden fazlas\u0131n\u0131 riske atmay\u0131n<\/td><\/tr> <tr><td>7<\/td><td>Emrinizi verin<\/td><td>Onaylamadan \u00f6nce detaylar\u0131 iki kez kontrol edin<\/td><\/tr> <tr><td>8<\/td><td>Stop-loss belirleyin<\/td><td>Ba\u015flang\u0131\u00e7ta %15-20 stop loss ile kendinizi koruyun<\/td><\/tr> <tr><td>9<\/td><td>Haber ak\u0131\u015f\u0131n\u0131 takip edin<\/td><td>FDA ve klinik deneme g\u00fcncellemelerine abone olun<\/td><\/tr> <tr><td>10<\/td><td>D\u00fczenli olarak g\u00f6zden ge\u00e7irin<\/td><td>Yat\u0131r\u0131m tezini \u00fc\u00e7 ayda bir yeniden de\u011ferlendirin<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Pocket Option Yeni Biyoteknoloji Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Neden Uygun?<\/h2> <p>ATAI gibi volatil biyoteknoloji hisselerinde denemek isteyenler i\u00e7in Pocket Option benzersiz avantajlar sunar:<\/p> <p><strong>Sadece $5 minimum depozito<\/strong> ile b\u00fcy\u00fck finansal taahh\u00fct olmadan k\u00fc\u00e7\u00fck pozisyonlar deneyebilirsiniz. Platformun <strong>1 dakikal\u0131k KYC s\u00fcreci<\/strong>\u2014sadece bir kimlik belgesi gerektirir\u2014sizi geleneksel arac\u0131 kurumlardan daha h\u0131zl\u0131 i\u015flem yapmaya ba\u015flat\u0131r. <strong>100+ para \u00e7ekme y\u00f6ntemi<\/strong> (kripto, e-c\u00fczdanlar ve banka kartlar\u0131 dahil) ile yat\u0131r\u0131mlar\u0131n\u0131z\u0131 y\u00f6netmede esneklik sa\u011flar.<\/p> <p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc volatil hisseleri takip etmeyi kolayla\u015ft\u0131r\u0131rken, d\u00fc\u015f\u00fck giri\u015f engeli ger\u00e7ek para ile pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fc ve risk y\u00f6netimi prati\u011fi yapman\u0131z\u0131 sa\u011flar, t\u00fcm yat\u0131r\u0131m portf\u00f6y\u00fcn\u00fcz\u00fc riske atmadan.<\/p> <h2>\ud83c\udf0d 2025'te Atai Life Sciences: Psikedelik T\u0131p \u00d6nc\u00fcs\u00fc<\/h2> <p>Atai Life Sciences, tedaviye diren\u00e7li durumlar i\u00e7in psikedelik t\u00fcrevli terapiler geli\u015ftirerek zihinsel sa\u011fl\u0131k devriminin \u00f6n saflar\u0131nda yer al\u0131yor. \u015eirketin mevcut $95,9 milyon nakit pozisyonu, depresyon i\u00e7in BPL-003, sosyal anksiyete i\u00e7in EMP-01 ve di\u011fer bir\u00e7ok yenilik\u00e7i bile\u015fi\u011fi i\u00e7eren iddial\u0131 bir \u00fcr\u00fcn hatt\u0131n\u0131 destekliyor.<\/p> <p><strong>2025 ilgin\u00e7 bilgi<\/strong>: Atai'nin genel merkezi, klinik deneme sonu\u00e7lar\u0131na g\u00f6re ayd\u0131nlatma ve ortam seslerini ayarlayan \"ruh hali alg\u0131lay\u0131c\u0131\" bir \u00e7al\u0131\u015fma alan\u0131na sahip\u2014BPL-003 Temmuz'da olumlu Faz 2b sonu\u00e7lar\u0131 g\u00f6sterdi\u011finde, t\u00fcm ofis otomatik olarak kutlama moduna ge\u00e7erek serotonin \u00fcretimi i\u00e7in optimize edilmi\u015f ayd\u0131nlatma sa\u011flad\u0131!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Atai Life Sciences Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2>\n<p><strong>20 A\u011fustos 2025 itibar\u0131yla Atai Life Sciences (ATAI) $3.99 seviyesinde i\u015flem g\u00f6r\u00fcyor<\/strong>\u2014birka\u00e7 ay \u00f6nceki 52 haftal\u0131k d\u00fc\u015f\u00fck seviyesi $1.03&#8217;ten kayda de\u011fer bir toparlanma. Hisse, %209,16&#8217;l\u0131k bir y\u0131ll\u0131k getiri ile patlay\u0131c\u0131 bir b\u00fcy\u00fcme g\u00f6sterdi ve bu y\u00fckselen sekt\u00f6r\u00fcn a\u015f\u0131r\u0131 volatilitesini ve potansiyelini ortaya koyuyor.<\/p>\n<p><strong>Takviminize not edin: 12 Kas\u0131m 2025 kesinlikle kritik.<\/strong> ATAI&#8217;nin 3. \u00e7eyrek kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 tarih bu ve tarihsel olarak bu a\u00e7\u0131klamalar hisse fiyat\u0131n\u0131 dramatik \u015fekilde etkiliyor. \u015eirket, beklentileri a\u015fma konusunda g\u00fc\u00e7l\u00fc bir model olu\u015fturdu\u201414 A\u011fustos 2025&#8217;teki 2. \u00e7eyrek raporu net zararda %51,6 azalma ile $27,7 milyon ve gelirde %163,4 art\u0131\u015f ile $719.000 olarak ger\u00e7ekle\u015fti.<\/p>\n<h3>Tarihsel Kazan\u00e7 Etkisi Analizi<\/h3>\n<p>Model a\u00e7\u0131k: ATAI beklentileri a\u015ft\u0131\u011f\u0131nda, yat\u0131r\u0131mc\u0131lar co\u015fkuyla tepki veriyor. Geriye d\u00f6n\u00fck testler, kazan\u00e7 a\u00e7\u0131klamalar\u0131ndan sonra hisse senedinin sekt\u00f6r rakiplerini <strong>%60 kazanma oran\u0131 ve a\u00e7\u0131klamalar\u0131 takip eden 10 g\u00fcnl\u00fck d\u00f6nemlerde ortalama %6,35 getiri ile<\/strong> geride b\u0131rakt\u0131\u011f\u0131n\u0131 g\u00f6steriyor. 2025 1. \u00e7eyrek kazan\u00e7lar\u0131 beklentileri %16,67 a\u015farken, 2. \u00e7eyrek $84,75M net zarar a\u00e7\u0131klamas\u0131na ra\u011fmen bu olumlu trend devam etti.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: M\u00fccadeleden Patlamaya<\/h2>\n<p>ATAI&#8217;nin son performans\u0131 dramatik bir d\u00f6n\u00fc\u015f\u00fcm hikayesi anlat\u0131yor. \u015eubat&#8217;tan A\u011fustos 2025&#8217;e kadar hisse, biyoteknoloji sekt\u00f6r\u00fcndeki en dikkat \u00e7ekici toparlanmalardan birini ya\u015fad\u0131:<\/p>\n<ul>\n<li><strong>\u015eubat 2025<\/strong>: $1,45-$2,56 aral\u0131\u011f\u0131nda i\u015flem g\u00f6rd\u00fc (%10,97 ayl\u0131k kazan\u00e7)<\/li>\n<li><strong>Mart 2025<\/strong>: $1,31-$1,73 aral\u0131\u011f\u0131na \u00e7ekildi (%20,93 d\u00fc\u015f\u00fc\u015f)<\/li>\n<li><strong>Nisan 2025<\/strong>: $1,15-$1,56 aral\u0131\u011f\u0131nda \u0131l\u0131ml\u0131 toparlanma (%10,29 kazan\u00e7)<\/li>\n<li><strong>May\u0131s 2025<\/strong>: $2,38 y\u00fcksek seviyesine patlama (%54,00 art\u0131\u015f)<\/li>\n<li><strong>Haziran 2025<\/strong>: $2,00-$2,64 aral\u0131\u011f\u0131nda konsolidasyon (%5,19 hafif d\u00fc\u015f\u00fc\u015f)<\/li>\n<li><strong>Temmuz 2025<\/strong>: Klinik kataliz\u00f6r etkisiyle $4,00 seviyesine s\u0131\u00e7rama (%51,14 patlama)<\/li>\n<\/ul>\n<p>Bu ivmenin kayna\u011f\u0131? <strong>Temmuz ay\u0131ndaki BPL-003 i\u00e7in Faz 2b sonu\u00e7lar\u0131<\/strong>\u2014depresyon i\u00e7in intranazal mebufotenin tedavileri\u2014&#8221;g\u00fc\u00e7l\u00fc, h\u0131zl\u0131 ve kal\u0131c\u0131 antidepresan etkiler&#8221; g\u00f6sterdi ve hisseleri tek seansta %20&#8217;den fazla y\u00fckseltti.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<h3>K\u0131sa Vadeli Projeksiyonlar (2025-2026)<\/h3>\n<p>Analistler, <strong>2025 i\u00e7in ortalama fiyat hedefini $4,28<\/strong> olarak \u00f6ng\u00f6r\u00fcyor; beklentiler $3,45 ile $5,11 aras\u0131nda de\u011fi\u015fiyor. 2026 i\u00e7in yapay zeka tabanl\u0131 modeller, klinik deneme sonu\u00e7lar\u0131n\u0131n belirsizli\u011fini yans\u0131tarak yakla\u015f\u0131k <strong>$4,06-$4,39<\/strong> aras\u0131nda daha m\u00fctevaz\u0131 bir b\u00fcy\u00fcme \u00f6ng\u00f6r\u00fcyor.<\/p>\n<h3>Uzun Vadeli Vizyon (2028-2030)<\/h3>\n<p>2028-2030 i\u00e7in spesifik hedefler biyoteknoloji yat\u0131r\u0131mlar\u0131n\u0131n spek\u00fclatif do\u011fas\u0131 nedeniyle mevcut de\u011fil, ancak temel piyasa dinamikleri muazzam potansiyel g\u00f6steriyor. Psikedelik t\u0131p pazar\u0131 2024&#8217;te 2,7 milyar dolardan <strong>2031&#8217;de 7,35+ milyar dolara<\/strong> b\u00fcy\u00fcmesi bekleniyor ve ATAI&#8217;nin geli\u015fmi\u015f \u00fcr\u00fcn hatt\u0131 \u00f6nemli pazar pay\u0131 yakalamaya haz\u0131r.<\/p>\n<p><strong>Sonu\u00e7: R\u0130SK TOLERANSI Y\u00dcKSEK yat\u0131r\u0131mc\u0131lar i\u00e7in G\u00dc\u00c7L\u00dc ALIM<\/strong>\u2014d\u00fc\u015f\u00fck de\u011ferleme, klinik ilerleme ve b\u00fcy\u00fck pazar potansiyelinin birle\u015fimi asimetrik bir risk-\u00f6d\u00fcl f\u0131rsat\u0131 yarat\u0131yor.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Reg\u00fclasyon belirsizli\u011fi<\/strong>: FDA onay s\u00fcre\u00e7leri \u00f6ng\u00f6r\u00fclemez ve ticarile\u015fmeyi y\u0131llarca geciktirebilir<\/li>\n<li><strong>Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong>: \u0130la\u00e7 adaylar\u0131n\u0131n %90&#8217;\u0131 geli\u015ftirme a\u015famas\u0131nda ba\u015far\u0131s\u0131z olur\u2014ATAI&#8217;nin t\u00fcm de\u011feri ba\u015far\u0131l\u0131 denemelere ba\u011fl\u0131<\/li>\n<li><strong>Nakit t\u00fcketimi<\/strong>: $95,9 milyon nakit pozisyonu mevcut t\u00fcketim h\u0131z\u0131nda ancak 2027 sonuna kadar yeterli<\/li>\n<li><strong>A\u015f\u0131r\u0131 volatilite<\/strong>: 1,55 beta de\u011feri, genel piyasadan %55 daha fazla volatilite anlam\u0131na gelir<\/li>\n<\/ul>\n<h3>2025-2026 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>At\u0131l\u0131m tedavi tan\u0131m\u0131<\/strong>: FDA, birka\u00e7 psikedelik program i\u00e7in h\u0131zland\u0131r\u0131lm\u0131\u015f stat\u00fc verdi<\/li>\n<li><strong>2025&#8217;te $140 milyon fon topland\u0131<\/strong>: Son fonlama g\u00fc\u00e7l\u00fc yat\u0131r\u0131mc\u0131 g\u00fcvenini g\u00f6steriyor<\/li>\n<li><strong>Beckley Psytech birle\u015fmesi<\/strong>: Stratejik birle\u015fme \u00fcr\u00fcn hatt\u0131n\u0131 ve klinik kaynaklar\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde geni\u015fletti<\/li>\n<li><strong>Sekt\u00f6r r\u00fczgarlar\u0131<\/strong>: Zihinsel sa\u011fl\u0131k tedavi pazar\u0131 %14,3 CAGR ile b\u00fcy\u00fcyor<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %2-5&#8217;inden fazlas\u0131n\u0131 ATAI gibi y\u00fcksek riskli biyoteknoloji hisselerine ay\u0131rmay\u0131n<\/li>\n<li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong>: Tek seferde b\u00fcy\u00fck al\u0131m yerine, birka\u00e7 ay boyunca k\u00fc\u00e7\u00fck miktarlarda sat\u0131n al\u0131n<\/li>\n<li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong>: 12 Kas\u0131m kazan\u00e7lar\u0131n\u0131 takip edin\u2014a\u00e7\u0131klama sonras\u0131 %5-10 d\u00fc\u015f\u00fc\u015fte al\u0131m yap\u0131n<\/li>\n<li><strong>Sekt\u00f6r i\u00e7inde \u00e7e\u015fitlendirin<\/strong>: Reg\u00fclasyon riskini yaymak i\u00e7in di\u011fer psikedelik hisseleri de de\u011ferlendirin<\/li>\n<\/ol>\n<p>Espiri: &#8220;ATAI ticareti, psikedelik terapi gibidir\u2014bazen zorlu anlara katlanman\u0131z gerekir ki \u00e7\u0131\u011f\u0131r a\u00e7an i\u00e7g\u00f6r\u00fclere ula\u015fabilesiniz. Ama ger\u00e7ek terapi seans\u0131n\u0131zda g\u00fcn i\u00e7i i\u015flem yapmaya kalkmay\u0131n!&#8221;<\/p>\n<h2>\u2705 Atai Life Sciences N.V. (ATAI) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir i\u015flem platformu se\u00e7in<\/td>\n<td>NASDAQ eri\u015fimi ve makul komisyon \u00fccretleri sundu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>Kimlik belgeleri sa\u011flay\u0131n\u2014genellikle 1-2 i\u015f g\u00fcn\u00fc s\u00fcrer<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Fon yat\u0131r\u0131n<\/td>\n<td>Tamamen kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>&#8220;ATAI&#8221; aramas\u0131 yap\u0131n<\/td>\n<td>\u015eirket ad\u0131 de\u011fil, borsa sembol\u00fcn\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n; volatil hisselerde piyasa emirlerinden ka\u00e7\u0131n\u0131n<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fc belirleyin<\/td>\n<td>Her i\u015flemde sermayenizin %1-2&#8217;sinden fazlas\u0131n\u0131 riske atmay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Emrinizi verin<\/td>\n<td>Onaylamadan \u00f6nce detaylar\u0131 iki kez kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Stop-loss belirleyin<\/td>\n<td>Ba\u015flang\u0131\u00e7ta %15-20 stop loss ile kendinizi koruyun<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>Haber ak\u0131\u015f\u0131n\u0131 takip edin<\/td>\n<td>FDA ve klinik deneme g\u00fcncellemelerine abone olun<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>D\u00fczenli olarak g\u00f6zden ge\u00e7irin<\/td>\n<td>Yat\u0131r\u0131m tezini \u00fc\u00e7 ayda bir yeniden de\u011ferlendirin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option Yeni Biyoteknoloji Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Neden Uygun?<\/h2>\n<p>ATAI gibi volatil biyoteknoloji hisselerinde denemek isteyenler i\u00e7in Pocket Option benzersiz avantajlar sunar:<\/p>\n<p><strong>Sadece $5 minimum depozito<\/strong> ile b\u00fcy\u00fck finansal taahh\u00fct olmadan k\u00fc\u00e7\u00fck pozisyonlar deneyebilirsiniz. Platformun <strong>1 dakikal\u0131k KYC s\u00fcreci<\/strong>\u2014sadece bir kimlik belgesi gerektirir\u2014sizi geleneksel arac\u0131 kurumlardan daha h\u0131zl\u0131 i\u015flem yapmaya ba\u015flat\u0131r. <strong>100+ para \u00e7ekme y\u00f6ntemi<\/strong> (kripto, e-c\u00fczdanlar ve banka kartlar\u0131 dahil) ile yat\u0131r\u0131mlar\u0131n\u0131z\u0131 y\u00f6netmede esneklik sa\u011flar.<\/p>\n<p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc volatil hisseleri takip etmeyi kolayla\u015ft\u0131r\u0131rken, d\u00fc\u015f\u00fck giri\u015f engeli ger\u00e7ek para ile pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fc ve risk y\u00f6netimi prati\u011fi yapman\u0131z\u0131 sa\u011flar, t\u00fcm yat\u0131r\u0131m portf\u00f6y\u00fcn\u00fcz\u00fc riske atmadan.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Atai Life Sciences: Psikedelik T\u0131p \u00d6nc\u00fcs\u00fc<\/h2>\n<p>Atai Life Sciences, tedaviye diren\u00e7li durumlar i\u00e7in psikedelik t\u00fcrevli terapiler geli\u015ftirerek zihinsel sa\u011fl\u0131k devriminin \u00f6n saflar\u0131nda yer al\u0131yor. \u015eirketin mevcut $95,9 milyon nakit pozisyonu, depresyon i\u00e7in BPL-003, sosyal anksiyete i\u00e7in EMP-01 ve di\u011fer bir\u00e7ok yenilik\u00e7i bile\u015fi\u011fi i\u00e7eren iddial\u0131 bir \u00fcr\u00fcn hatt\u0131n\u0131 destekliyor.<\/p>\n<p><strong>2025 ilgin\u00e7 bilgi<\/strong>: Atai&#8217;nin genel merkezi, klinik deneme sonu\u00e7lar\u0131na g\u00f6re ayd\u0131nlatma ve ortam seslerini ayarlayan &#8220;ruh hali alg\u0131lay\u0131c\u0131&#8221; bir \u00e7al\u0131\u015fma alan\u0131na sahip\u2014BPL-003 Temmuz&#8217;da olumlu Faz 2b sonu\u00e7lar\u0131 g\u00f6sterdi\u011finde, t\u00fcm ofis otomatik olarak kutlama moduna ge\u00e7erek serotonin \u00fcretimi i\u00e7in optimize edilmi\u015f ayd\u0131nlatma sa\u011flad\u0131!<\/p>\n"},"faq":[{"question":"Atai Life Sciences hisseleri nereden al\u0131n\u0131r?","answer":"Atai Life Sciences hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6r\u00fcr. G\u00fcvenilir bir arac\u0131 kurum veya online i\u015flem platformu \u00fczerinden ATAI sembol\u00fc ile al\u0131m yapabilirsiniz."},{"question":"Atai Life Sciences hisseleri ne kadar risklidir?","answer":"ATAI hisseleri y\u00fcksek volatiliteye sahiptir ve biyoteknoloji sekt\u00f6r\u00fcndeki klinik deneme sonu\u00e7lar\u0131na ba\u011fl\u0131 olarak \u00f6nemli dalgalanmalar g\u00f6sterebilir. Y\u00fcksek risk, y\u00fcksek getiri potansiyeli ta\u015f\u0131r."},{"question":"Atai Life Sciences'in gelecekteki fiyat beklentileri nelerdir?","answer":"Analistler 2025 i\u00e7in ortalama $4,28 fiyat hedefi \u00f6ng\u00f6r\u00fcrken, 2026 i\u00e7in $4,06-$4,39 aral\u0131\u011f\u0131nda daha m\u00fctevaz\u0131 bir b\u00fcy\u00fcme beklenmektedir. Uzun vadede pazar potansiyeli olduk\u00e7a y\u00fcksektir."},{"question":"Atai Life Sciences'in en \u00f6nemli riskleri nelerdir?","answer":"Reg\u00fclasyon belirsizli\u011fi, klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131, nakit t\u00fcketimi ve y\u00fcksek volatilite ba\u015fl\u0131ca risklerdir."},{"question":"Yeni ba\u015flayan biri ATAI hissesi al\u0131rken nelere dikkat etmeli?","answer":"Portf\u00f6y\u00fcn\u00fcz\u00fcn k\u00fc\u00e7\u00fck bir y\u00fczdesiyle ba\u015flay\u0131n, dolar maliyeti ortalamas\u0131 yap\u0131n, fiyat uyar\u0131lar\u0131 kurun ve sekt\u00f6rde \u00e7e\u015fitlendirme yaparak riskleri azalt\u0131n."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Atai Life Sciences hisseleri nereden al\u0131n\u0131r?","answer":"Atai Life Sciences hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6r\u00fcr. G\u00fcvenilir bir arac\u0131 kurum veya online i\u015flem platformu \u00fczerinden ATAI sembol\u00fc ile al\u0131m yapabilirsiniz."},{"question":"Atai Life Sciences hisseleri ne kadar risklidir?","answer":"ATAI hisseleri y\u00fcksek volatiliteye sahiptir ve biyoteknoloji sekt\u00f6r\u00fcndeki klinik deneme sonu\u00e7lar\u0131na ba\u011fl\u0131 olarak \u00f6nemli dalgalanmalar g\u00f6sterebilir. Y\u00fcksek risk, y\u00fcksek getiri potansiyeli ta\u015f\u0131r."},{"question":"Atai Life Sciences'in gelecekteki fiyat beklentileri nelerdir?","answer":"Analistler 2025 i\u00e7in ortalama $4,28 fiyat hedefi \u00f6ng\u00f6r\u00fcrken, 2026 i\u00e7in $4,06-$4,39 aral\u0131\u011f\u0131nda daha m\u00fctevaz\u0131 bir b\u00fcy\u00fcme beklenmektedir. Uzun vadede pazar potansiyeli olduk\u00e7a y\u00fcksektir."},{"question":"Atai Life Sciences'in en \u00f6nemli riskleri nelerdir?","answer":"Reg\u00fclasyon belirsizli\u011fi, klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131, nakit t\u00fcketimi ve y\u00fcksek volatilite ba\u015fl\u0131ca risklerdir."},{"question":"Yeni ba\u015flayan biri ATAI hissesi al\u0131rken nelere dikkat etmeli?","answer":"Portf\u00f6y\u00fcn\u00fcz\u00fcn k\u00fc\u00e7\u00fck bir y\u00fczdesiyle ba\u015flay\u0131n, dolar maliyeti ortalamas\u0131 yap\u0131n, fiyat uyar\u0131lar\u0131 kurun ve sekt\u00f6rde \u00e7e\u015fitlendirme yaparak riskleri azalt\u0131n."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Atai Life Sciences N.V. (ATAI) Hisseleri Nas\u0131l Al\u0131n\u0131r - Atai Life Sciences N.V. (ATAI) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Atai Life Sciences N.V. (ATAI) Hisseleri Nas\u0131l Al\u0131n\u0131r - Atai Life Sciences N.V. (ATAI) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-20T14:16:15+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Atai Life Sciences N.V. (ATAI) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Atai Life Sciences N.V. (ATAI) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-20T14:16:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/\"},\"wordCount\":25,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/\",\"name\":\"Atai Life Sciences N.V. (ATAI) Hisseleri Nas\u0131l Al\u0131n\u0131r - Atai Life Sciences N.V. (ATAI) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp\",\"datePublished\":\"2025-08-20T14:16:15+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Atai Life Sciences N.V. (ATAI) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Atai Life Sciences N.V. (ATAI) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Atai Life Sciences N.V. (ATAI) Hisseleri Nas\u0131l Al\u0131n\u0131r - Atai Life Sciences N.V. (ATAI) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/","og_locale":"tr_TR","og_type":"article","og_title":"Atai Life Sciences N.V. (ATAI) Hisseleri Nas\u0131l Al\u0131n\u0131r - Atai Life Sciences N.V. (ATAI) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-20T14:16:15+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Atai Life Sciences N.V. (ATAI) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Atai Life Sciences N.V. (ATAI) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-20T14:16:15+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/"},"wordCount":25,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/","name":"Atai Life Sciences N.V. (ATAI) Hisseleri Nas\u0131l Al\u0131n\u0131r - Atai Life Sciences N.V. (ATAI) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp","datePublished":"2025-08-20T14:16:15+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Atai Life Sciences N.V. (ATAI) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Atai Life Sciences N.V. (ATAI) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":341181,"slug":"how-to-buy-atai-life-sciences-nv","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Atai Life Sciences N.V. (ATAI) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Atai Life Sciences N.V. (ATAI)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/"},"pt_AA":{"locale":"pt_AA","id":341179,"slug":"how-to-buy-atai-life-sciences-nv","post_title":"Como comprar a\u00e7\u00f5es da Atai Life Sciences N.V. (ATAI) - Investimento em a\u00e7\u00f5es da Atai Life Sciences N.V. (ATAI)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-atai-life-sciences-nv\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/341180","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=341180"}],"version-history":[{"count":1,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/341180\/revisions"}],"predecessor-version":[{"id":341183,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/341180\/revisions\/341183"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334090"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=341180"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=341180"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=341180"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}